Detection of vancomycin-resistant enterococci and vancomycin-resistance genes in patients hospitalized in the pediatric intensive care unit

Yıl 2022, Cilt: 13 Sayı: 47, 405 - 411, 15.12.2022

Ömer Okuyan Necmi Aksaray Suna Kızılyıldırım Cansu Önlen Güneri Fatih Köksal

https://doi.org/10.17944/mkutfd.1113953

Öz

Objective: Vancomycin-resistant enterococci (VRE) infection and colonization are seen increasingly frequently, especially among intensive care unit (ICU) patients. In this study, the aim was to detect VRE in swab samples taken from patients hospitalized in the Pediatric ICU (PICU), colonization, and to investigate the clonal relationship between isolates.

Method: In the present study, swab samples were taken from the external auditory canal (EAC), umbilical region, and rectal region from 82 patients hospitalized in the Çukurova University Balcalı Hospital PICU. The 246 swab samples from patients were inoculated on Kanamycin-Esculin-Azide agar. Isolates were identified with the help of the BBL Crystal Gram-Positive identification system. The susceptibility of the isolates to vancomycin (30 μg) was investigated by Kirby-Bauer disk diffusion method according to CLSI criteria. VanA-VanB genes in phenotypically defined vancomycin-resistant enterococci were investigated by Polymerase Chain Reaction (PCR) method. The clonal relationship between vancomycin-susceptible (VSE) and -resistant enterococci was determined by the SmaI-PFGE method.

Results: A total of 49 (20.3%) enterococcal strains were isolated from 246 swab samples from the patients, of which 14 (28.5%) were VRE. Of the enterococci isolates, 27 (55.10%) were E. faecium and 13 (26.53%) were E. feacalis. While VanA type resistance was detected in 11 of the vancomycin-resistant E. faecium and E. feacalis isolates, VanB type resistance was not detected in any sample. There was no significant clonal relationship between the isolates.

Conclusion: Although the prevalence of VRE in the PICU was high throughout the study, no enterococcal infection was observed.

Anahtar Kelimeler

Vancomycin-resistant enterococci, VanA, VanB, PCR, SmaI-PFGE

Destekleyen Kurum

Cukurova University

Proje Numarası

Cukurova University Scientific Research Projects (TF2011 LTP24)

Teşekkür

We would like to acknowledge Cukurova University for financially supported this project.

Çocuk yoğun bakım ünitesinde yatan hastalarda vankomisine dirençli enterokok ve vankomisine dirençli genlerin tespiti

Öz

Amaç: Vankomisine dirençli enterokok (VRE) enfeksiyonu ve kolonizasyonu, özellikle yoğun bakım ünitesi (YBÜ) hastalarında giderek artan sıklıkta görülmektedir. Bu çalışmanın amacı, Pediatrik YBÜ’de (PYBÜ) yatan hastalardan alınan sürüntü örneklerinde VRE’yi saptamak, kolonizasyonu ve izolatlar arasındaki klonal ilişkiyi araştırmaktı.

Yöntem: Çalışmada, Çukurova Üniversitesi Balcalı Hastanesi PYBÜ’nde yatan 82 hastadan dış kulak yolu (DKY), göbek bölgesi ve rektal bölgeden sürüntü örnekleri alındı. Hastalardan alınan 246 sürüntü örneği Kanamisin-Esculin-Azide agara inoküle edildi. İzolatlar, BBL Crystal Gram-Positive tanımlama sistemi yardımıyla tanımlandı. İzolatların vankomisine (30 μg) duyarlılıkları Kirby-Bauer disk difüzyon yöntemi ile CLSI kriterlerine göre araştırıldı. Fenotipik olarak tanımlanmış vankomisine dirençli enterokoklarda VanA-VanB genleri, Polimeraz Zincir Reaksiyonu (PCR) yöntemi ile araştırıldı. Vankomisine duyarlı (VSE) ve dirençli enterokoklar arasındaki klonal ilişki SmaI-PFGE yöntemi ile belirlendi.

Bulgular: Hastalardan alınan 246 sürüntü örneğinden 14’ü (%28.5) VRE olan toplam 49 (%20.3) enterokok suşu izole edildi. Enterokok izolatlarının 27’si (%55.10) E. faecium ve 13’ü (%26.53) E. feacalis idi. Vankomisine dirençli E. faecium ve E. feacalis izolatlarının 11’inde VanA tipi direnç tespit edilirken, hiçbir örnekte VanB tipi direnç tespit edilmedi. İzolatlar arasında önemli bir klonal ilişki yoktu.

Sonuç: Çalışma boyunca PYBÜ’de VRE prevalansı yüksek olmasına rağmen enterokok enfeksiyonu gözlenmedi.

Anahtar Kelimeler

Vankomisine dirençli enterokoklar, VanA, VanB, PCR, SmaI-PFGE

Proje Numarası

Cukurova University Scientific Research Projects (TF2011 LTP24)

Kaynakça

• Cotton MJ, and Packer CD. Vancomycin-resistant Enterococcus faecium empyema in an asplenic patient. Cureus .2018;10(8):3227. https://doi.org/10.7759/cureus.3227.
• Kim HS, Kim DH, Yoon HJ, Lee WJ, Woo SH, et al. Factors associated with vancomycin-resistant enterococcus colonization in patients transferred to emergency departments in Korea. Journal Korean. Medical Science. 2018;33(48):295. https://doi.org/10.3346/jkms.2018.33.e295.
• Farhadi R, Saffar MJ, Monfared FT, Larijani LV, Kenari SA et al. Prevalence, risk factors and molecular analysis of vancomycin-resistant enterococci colonization in a referral neonatal intensive care unit: A prospective study in northern Iran. Journal of Global Antimicrobial Resistance. 2022;30:474-479. https://10.1016/j.jgar.2022.05.019.
• Gouliouris T, Raven KE, Ludden C, Blane B, Corander J, et al. Genomic surveillance of Enterococcus faecium reveals limited sharing of strains and resistance genes between Livestock and humans in the United Kingdom. mBio. 2018;9. ttps://doi.org/10.1128/mBio.01780-18.
• Deshpande VR, Karmarkar MG, and Mehta PR. Prevalence of multidrug-resistant enterococci in a tertiary care hospital in Mumbai, India. The Journal of Infection in Developing Countries. 2013;7:155-158. https://doi.org/10.3855/jidc.3018.
• Lee SC, Lee CW, Shih TC, See LC, Chu CM, et al. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan. Journal of Microbiology, Immunology and Infection. 2016; 49:749-759. https://doi.org/10.1016/j.jmii.2015.11.002.
• Jafari, S, Abdollahi A, Sabahi M, Salehi M, Asadollahi-Amin A, et al. An Update to enterococcal bacteremia: epidemiology, resistance, and outcome. Infectious Disorders Drug Targets. 2022;22(2):170322187568. https://10.2174/1871526520999201103191829.
• Huh HJ. Evaluation of the intron vre vanA/vanB real-time PCR assay for detection of vancomycin-resistant enterococci. Annals of Laboratory Medicine. 2015;35:76-81. https://doi.org/10.3343/alm.2015.35.1.76.
• Kuo AJ, Shu JC, Liu TP, Lu JJ, Lee MH, et al. Vancomycin-resistant Enterococcus faecium at a university hospital in Taiwan, 2002-2015: Fluctuation of genetic populations and emergence of a new structure type of the Tn1546-like element. Journal of Microbiology, Immunology and Infection. 2018;(51):821-828. https://doi.org/10.1016/j.jmii.2018.08.008.
• Levitus M, Rewane A, and Perera TB. Vancomycin-resistant enterococci, in StatPearls. 2022:Treasure Island (FL).
• Dutka-Malen S, Mohnas C, Arthur M and Courvalin P. The vanA glycopeptide resistance protein is related to D-alanyl-Dalanine ligase cell wall biosynthesis enzymes. Molecular and General Genetics. 1990;224:364-72. https://doi.org/10.1007/BF00262430.
• Purohit G, Gaind R, Dawar R, Verma PK, Aggarwal K.C, Sardana R, et al. Characterization of vancomycin resistant enterococci in hospitalized patients and role of gut colonization. Journal of Clinical Diagnostic Research. 2017;11(9):01-05. https://doi.org/10.7860/JCDR/2017/25988.10548.
• Salem-Bekhit MM, Moussa IMI, Muharram MM, Alanazy FK, Hefni HM. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Indian Journal of Medical Microbiology . 2012;30:44-51. https://doi.org/10.4103/0255-0857.93032.
• Akturk H, Sutcu M, Somer A, Acar M, Karapınar BA, et al. Vancomycin-resistant enterococci colonization in a neonatal intensive care unit: who will be infected? The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29:3478-82. https://doi.org/10.3109/14767058.2015.1132693.
• Akturk H, Sutcu M, Somer A, Karaman S, Acar M, et al. Results of four-year rectal vancomycin-resistant enterococci surveillance in a pediatric hematology-oncology ward: from colonization to ınfection. Turkish Journal Haematology. 2016;33:244-7. https://doi.org/10.4274/tjh.2015.0368.
• Cilo BD, Ağca H, Efe K, Sınırtaş M, Çelebi S, et al. Investigation of vancomycin resistant Enterococcus faecium outbreak in neonatal intensive care unit. International Journal of Clinical and Experimental Medicine. 2014;7:5342-7.
• Sutcu M, Akturk H, Acar M, Salman N, Aydın D et al. Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients. American Journal of Infection Control. 2016;44:515-9. https://doi.org/10.1016/j.ajic.2015.11.026.
• Yi R, Selda Aslan S, Cıtak Ç, Değirmenci S. Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children’s Hospital, Turkey. Mikrobiyoloji Bülteni. 2011;45:646-54.
• Ziakas PD, Thapa R, Rice LB, and Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS One. 2013;8:75658. https://doi.org/10.1371/journal.pone.0075658.
• Dutka-Malen S, Evers S, and Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology. 1995;33:1434. https://doi.org/10.1128/JCM.33.5.1434-1434.1995.
• Nourse C, Murphy H, Byrne C, O’Meara A, Breatnach F, Kaufmann M, et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. European Journal of Pediatrics. 1998;157:20-7. https://doi.org/10.1007/s004310050760.
• Zhang YZ and Singh S. Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us. World Journal of Critical Care Medicine. 2015;4:13-28. https://doi.org/10.5492/wjccm.v4.i1.13.
• Amberpet R, Sistla S, Parija SC, Rameshkumar R. Risk factors for intestinal colonization with vancomycin resistant enterococci’ A prospective study in a level III pediatric intensive care unit. Journal of Laboratory Physicians. 2018;10:89-94. https://doi.org/10.4103/JLP.JLP_32_17.
• Furtado GHC, Martins ST, Coutinho AP, Wey SB, Medeiros E. Prevalence and factors associated with rectal vancomycinresistant enterococci colonization in two intensive care units in Sao Paulo, Brazil. The Brazilian Journal of Infectious Diseases. 2005;9:64-9. https://doi.org/10.1590/s1413-86702005000100011.
• Javadi A, Behrooz A, Farzin K, Saied T, Sina M, et al. Prevalence of vancomycin resistant enterococci colonization in gastrointestinal tract of hospitalized patients. Iran Journal of Clinical Infectious Diseases. 2008;3:317-141.
• Jahansepas A, Rezaee MA, Hasani A, Sharifi Y, Farzami MR, et al. Molecular epidemiology of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium ısolated from clinical specimens in the Northwest of Iran. Microbial Drug Resistance. 2018;24:1165-1173. https://doi.org/10.1089/mdr.2017.0380.
• Lee SC., Wu MS, Shih HJ, Huang SH, Chiou MJ, Bakın LC et al. Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan. BMC Infectious Diseases. 2013;13:163. https://doi.org/10.1186/1471-2334-13-163.
• Kim YJ., Kim SI, Kim YR, Lee JY, Parkı YJ, Kang AW. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. American Journal of Infection Control. 2012;40:1018-9. https://doi.org/10.1016/j.ajic.2012.01.009.
• Ongut G, Kilinckaya H, Baysan BO, Ogunc D, Colak D, et al. Evaluation of Brilliance VRE agar for the detection of vancomycin-resistant enterococci in rectal swab specimens. Journal of Medical Microbiology. 2013; 62:661-662. https://doi.org/10.1099/jmm.0.052845-0.